Release Date: 22/04/14 08:36 Summary: Change in substantial holding from MTE Price Sensitive: No Download Document 43.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%